- Home
- TELO vs AKYA Comparison
TELO vs AKYA Comparison
Compare TELO & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- AKYA
- Stock Information
- Founded
- TELO 2021
- AKYA 2015
- Country
- TELO United States
- AKYA United States
- Employees
- TELO N/A
- AKYA N/A
- Industry
- TELO
- AKYA Medical Specialities
- Sector
- TELO
- AKYA Industrials
- Exchange
- TELO NYSE
- AKYA Nasdaq
- Market Cap
- TELO 58.6M
- AKYA 56.1M
- IPO Year
- TELO 2024
- AKYA 2021
- Fundamental
- Price
- TELO $1.53
- AKYA $1.34
- Analyst Decision
- TELO
- AKYA Hold
- Analyst Count
- TELO 0
- AKYA 7
- Target Price
- TELO N/A
- AKYA $2.51
- AVG Volume (30 Days)
- TELO 408.8K
- AKYA 437.7K
- Earning Date
- TELO 08-12-2025
- AKYA 08-04-2025
- Dividend Yield
- TELO N/A
- AKYA N/A
- EPS Growth
- TELO N/A
- AKYA N/A
- EPS
- TELO N/A
- AKYA N/A
- Revenue
- TELO N/A
- AKYA $79,961,000.00
- Revenue This Year
- TELO N/A
- AKYA $7.26
- Revenue Next Year
- TELO N/A
- AKYA $11.44
- P/E Ratio
- TELO N/A
- AKYA N/A
- Revenue Growth
- TELO N/A
- AKYA N/A
- 52 Week Low
- TELO $1.52
- AKYA $0.93
- 52 Week High
- TELO $8.40
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- TELO 29.64
- AKYA 60.01
- Support Level
- TELO $1.65
- AKYA $1.20
- Resistance Level
- TELO $1.81
- AKYA $1.33
- Average True Range (ATR)
- TELO 0.17
- AKYA 0.09
- MACD
- TELO -0.01
- AKYA 0.01
- Stochastic Oscillator
- TELO 1.03
- AKYA 98.93
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.